Fri, Sep 19, 2014, 11:30 AM EDT - U.S. Markets close in 4 hrs 30 mins

Recent

% | $
Quotes you view appear here for quick access.

Neurocrine Biosciences Inc. Message Board

  • ggrter ggrter Jan 10, 2014 9:39 AM Flag

    insider sold this week, it did not take very long!

    Gorman Kevin Charles who is President and CEO at Neurocrine Biosciences sold 108,000 shares at $16.76 on Jan. 8, 2014. Following this transaction, the President and CEO owned 177,202 shares meaning that the stake was reduced by 37.87% with the 108,000-share transaction.

    OBrien Christopher Flint who is Chief Medical Officer at Neurocrine Biosciences sold 5,000 shares at $17.50 on Jan. 8, 2014. Following this transaction, the Chief Medical Officer owned 94,794 shares meaning that the stake was reduced by 5.01% with the 5,000-share transaction.

    Coughlin Timothy P who is Chief Financial Officer at Neurocrine Biosciences sold 70,000 shares at $16.75 on Jan. 8, 2014. Following this transaction, the Chief Financial Officer owned 96,124 shares meaning that the stake was reduced by 42.14% with the 70,000-share transaction.

    Bozigian Haig P. who is Chief Development Officer at Neurocrine Biosciences sold 25,000 shares at $17.50 on Jan. 8, 2014. Following this transaction, the Chief Development Officer owned 76,954 shares meaning that the stake was reduced by 24.52% with the 25,000-share transaction.

    Grigoriadis Dimitri E. who is Chief Research Officer at Neurocrine Biosciences sold 25,000 shares at $17.50 on Jan. 8, 2014. Following this transaction, the Chief Research Officer owned 75,433 shares meaning that the stake was reduced by 24.89% with the 25,000-share transaction.

 
NBIX
16.42+0.03(+0.18%)11:30 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.